Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002607
Filing Date
2019-04-26
Accepted
2019-04-26 09:02:05
Documents
3
Period of Report
2019-06-19
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238595zdef14a.htm DEF 14A 791053
2 G25422BCI001.GIF g25422bci001.gif GRAPHIC 162483
3 G25422BCI002.GIF g25422bci002.gif GRAPHIC 92241
  Complete submission text file 0001047469-19-002607.txt   1143217
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 19769555
SIC: 2835 In Vitro & In Vivo Diagnostic Substances